Chemoinformaics analysis of Amyl methyl disulfide
| Molecular Weight | 150.312 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.2 | nRig | 0 |
| Exact Molecular Weight | 150.054 | nRing | 0 |
| Solubility: LogS | -4.46 | nHRing | 0 |
| Solubility: LogP | 3.403 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.1551 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.436 |
| Synth | 2.657 |
| Natural Product Likeliness | 0.535 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.035 |
| HIA | 0.004 |
| CACO-2 | -4.34 |
| MDCK | 0.0000294 |
| BBB | 0.866 |
| PPB | 0.824413 |
| VDSS | 1.347 |
| FU | 0.192813 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.881 |
| CYP2c19-inh | 0.727 |
| CYP2c19-sub | 0.86 |
| CYP2c9-inh | 0.154 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.774 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.23 |
| CL | 13.247 |
| T12 | 0.289 |
| hERG | 0.071 |
| Ames | 0.101 |
| ROA | 0.103 |
| SkinSen | 0.936 |
| Carcinogencity | 0.443 |
| EI | 0.992 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.018 |
| Antiviral | No |
| Prediction | 0.951689 |